TBA (last known deadline was July 16, 2012)
JDRF supports highly innovative basic and clinical research that is at the developmental stage by providing seed money for investigative work based on sound scientific hypotheses for which preliminary data are insufficient for a regular research grant but that are likely to lead to important results for the treatment of diabetes and its complications. These grants provide one year of support for a maximum of $100,000 in direct costs and indirect costs of 10%, for a total of $110,000. These grants are not renewable